Immunex Message Board - Msg: 6490231

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunex

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LemurHouse who wrote (258)	11/19/1998 8:02:00 PM
From: Anthony Wong	Read Replies (1) of 656

16:46 T =Immunex Stk -3: Enbrel Being Explored For Added Indications Medicare does not reimburse for home use drugs. But Enbrel, which is a self injection, has already had some Medicare reimbursement on a case-by-case basis in certain states, Franklin Global Healthcare Fund's Von Emster said. An Immunex spokesman said the company, which doesn't comment on stock fluctuations, hasn't made any news announcements Thursday. Enbrel was approved Nov. 2 and launched simultaneously. The drug is being explored for added indications, including use for juvenile rheumatoid arthritis and congestive heart failure. -Melanie Trottman 201-938-5287 (END) DOW JONES NEWS 11-19-98 04:46 PM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next